Member Info for upupandawaybby

Db hasn't even attempted to sell to the NHS/Government
If he had we would have been informed
Not our target market - Absolutely boils my p1ss, why spend time and money going for CE approval if we are going to sell to India or anywhere else where CE approval is irrelevant. Surely that would have been the first port of call to contact relevant countries authorities not wait months. This falls on DB

Sales , profit and growth are all we are interested in as a pi and we have none and that is due to the woeful S&M team headed up by DB

Absolute dog ****e

Have SNG as the only co in their portfolio were the sp drops and instead of panicking think woohoo top up time?

I'd happily see a drop to 150 i'd be ecstatic

That's how good RM & the team are, imagine the patent they filed back in 2009 was via nebuliser
Interferons would now already be in market making billions via face mask or even a bloody e-cig lol

Adding the word inhalation is literally worth multiple billions and now we have also replicated that patent to include steroids!

Should I now be doubling my personal targets as we can now treat early stages at home and this combination should also enable us to cover the other market of advanced/severe cases on hospitalised patients?

Some serious thinking to be done

Wasn't taken as one buddy, you're right I could and should have expanded

Richlist - What are you on about?

Human coronaviruses were first identified in the mid-1960s. The seven coronaviruses that can infect people are:

Common human coronaviruses
229E (alpha coronavirus)
NL63 (alpha coronavirus)
OC43 (beta coronavirus)
HKU1 (beta coronavirus)
Other human coronaviruses
MERS-CoV (the beta coronavirus that causes Middle East Respiratory Syndrome, or MERS)
SARS-CoV (the beta coronavirus that causes severe acute respiratory syndrome, or SARS)
SARS-CoV-2 (the novel coronavirus that causes coronavirus disease 2019, or COVID-19)

These are viral/respiratory diseases & all fall under our patent that protects delivery method via inhalation

Hi B2 - This literally is the holy grail and is just a puff once a day on a nebuliser no hospital no injections absolute worldwide game changer.

Nip to a chemist and buy one soon?

You are right though, I have done a previous post about the savings both financially, time wise & resource wise to the NHS

Thanks Dave I wasn't aware very good info

Thanks Deedo, very Interested to know why you have a personal target of £7.77

Do you mind elaborating please?

Thanks, Harley I posted this a while back i've just edited a few lines and re - posted due to the patent discussions.

My research posts a few now I do occasionally re-post some of my older stuff when there seems to be gloom on the board and SP dip.

I'll post some more of my older stuff

haven’t even top sliced there is no risk here for me personally and only an sp significantly higher will prize this asset from me.

The new data has surprised us, the scientists & Rm no one expected SNG001 to work so well with steroids
Hence the reason that new patents were filed the day after mega monday.

This part adds so much more value to SNG001 and is being hugely overlooked

GLA

people that have just invested as it's big news may not be aware of how significant this is, a vaccine takes years to develop and are for a particular strain. By the time one has been developed for covid-19 it will have mutated into covid 22 for example and be useless NVM vaccine is a poisonous word and a man made concoction. SNG have the viral treatment (A naturally occuring protein our body produces) for sars mers asthma copd future strains and mutations and they own the patents in UK europe us and Asia. This literally is the holy grail and is just a puff once a day on a nebuliser no hospital no injections absolute worldwide game changer

How far will it go? 150 million shares in issue at mcap of £500M gives us £3.60 per share, however I feel there is no chance of Richard & co dedicating 15 years of their life and have the golden ticket and not getting their just rewards.

When you have every major pharma in the world bidding for the only company to currently have what looks like the answer and that answer will bring in £3-5 billion every flu season BEFORE you even look at what COPD brings in you start to see how ridiculous a £3.60 Finncap target really is

Based on cost and demand coupled with the fact a big pharma can buy us or miss out they can't then go and buy something else I see absolutely no reason why we wouldn't fetch at least £2 billion giving us roughly again £13.50 a share but I believe £5 billion would be £33.50 a share and more realistic.

Multi partners, potentially AZ for Europe, Gilead and CDC for US, Biogene supplier of IFN -b?

Billions up front maybe £2B from each AZ & Gilead/CDC

RM mentioned Government funding later that day announcement of £50 million for potential breakthrough treatments etc

What next, FDA approval, peer review, EMA, home trial results, partnership/takeover news

First presidential debate fast approaching 29th September at Western University

IN 1995 The Western Reserve University filed a patent for delivery of IFNb and was granted in 2000
This expired in 2017 https://patents.google.com/patent/US6030609A/en

Here's the very interesting part, the uni is funded by CDC (Centers for disease control and prev) along with many other bodies
Why has Trump chosen to host the First Presidential debate here?
Could it be his TRUMP card (See what I did there lol) and announce a partnership with SNG and the Western uni?

My educated guess connecting dots is CDC will fund the buyout of SNG and this is already agreed behind closed doors so Trump can announce it was Americas great great education & University that saw this coming and saved the world.

Pure speculation on my part but I find it interesting non the less

Points in this post, some are fact, some are educated predictions with solid foundation and some are pure speculation.

What doesn’t change is the fact this works, it’s protected, it’s worth billions and we have partners/buyers in place

I’m still holding every share and h

RM reply in July webinar– “Our intention is to make MILLIONS of doses available later this year!”

Note available, not start manufacturing or in the process – AVAILABLE! That leaves 12 weeks or so

Potential figures £100 per dose, 14 days per course at just 5mill doses per year

£500milion sales would suggest £5billion market cap so that gives us about £33.50 per share

SNG 001 - Shelf life 3 years

Governments worldwide can stock pile it in bucket loads

Patent protected for delivery method, now also patent pending for combination with steroid
(There’s minimum 9 years left 2009 on original)

SNG001 is a viral treatment (Interferon-b A naturally occurring protein our body produces) for sars mers asthma copd future strains and mutations and they own the delivery method patents in UK, europe & US.

We are the only therapeutic in the world that has been granted trials for home use, patents worldwide for the most effective way of delivery of interferon b, inhaled direct to infected area,
We have been fast tracked as urgent public health study due to the evidence supporting the drug by NIHR, expedited approval from BOTH MHRA & HRA, The World Health Organization (WHO) identified us as a potential therapeutic as the ONLY phase 2/3 in the world via inhalation
We are now on multiple platforms in America also been added to more German ones
Polar (a massive £15B ii) paid a premium for their shares buying 7% of the company after we spiked.
(Coincides nicely with Polar CEO Gavin Rochussen being issued a further 145,000 shares in Polar the day after they bought SNG shares that he can’t sell until July 2022)
Venrock followed suit

This literally is the holy grail and is just a puff once a day on a nebuliser no hospital no injections absolute worldwide game changer.

Nip to a chemist and buy one soon?

Couple of questions i've been asked
Does it matter only 100 patients in trial? Not really as IFN-b has been used for years and is a naturally occurring protein in our bodies not some mad scientist concocted drug. The trial was gold standard double blind placebo, this particular trial had 100 people but it's been used and tested on humans for 15 years

Out of interest what would stop another pharma making the same product.?
Plenty of pharmas already use IFN-b, the huge difference is they can only administer it through IV due to the fact that SNG owns the worldwide patent since 2009 of the delivery method of IFN-b virally. What it means is we already know interferons work and already have a benefit but through IV it's a far higher dose, more costly, less effective, more side effects, takes longer to get to the infected area (lungs) less gets there and so on. SNG protected method is no injections 100% delivery direct into lungs immediately.

What about a vaccine? Done this to death A lot of people that have just invested as it's big news may not be aware of how significant this is, a vaccine takes years to develop and are for a pa

Existing patents has SARS MERS Viral infections, doesn't need COVID it's bullet proof hence no other Pharma in the world has even attempted to work on a viral delivery
New patents are for the combined drug SNG001 and steroids

Not of it's an offer in principal based on x & y so it doesn't have to be reported until they want it to once all their ducks are in a row

Mega Monday 20th July, patent app filed 21st July

How long does it take to prepare a patent application, couple of weeks?

They knew all along it worked and worked better than anything else in the world

Golden egg, this is the Golden Goose

Basically we’ve been offered a couple billion and the advisors have said you’re alright we know what thinks worth and are further protecting and increasing the value

our immediate priority is to progress SNG001 as a therapeutic for COVID-19. Together with our advisors we are working to protect the value of this drug for shareholders and commercial partners over the longer term."

Yep one piece of news out the way roll on the next

I agree and think the RNS was an aperitif, I am expecting another 1 possibly 2 RNS to follow very soon.
Approvals and licensing t/o
After confirmation of these two then 2B-5B is still firmly my personal target £13.50 - £33.50 a share

https://www.thearmchairtrader.com/our-picks-august-2020/

Hoping my very painful long holding here pays off this month